{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:35:46Z","timestamp":1795030546410,"version":"4.10.2"},"reference-count":8,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:p>This Viewpoint discusses the ophthalmic device, red light therapy, for myopia treatment in children and adolescents in China, including its development and use, safety concerns, and implications surrounding recent regulatory changes and reclassification of this device.<\/jats:p>","DOI":"10.1001\/jamaophthalmol.2024.5977","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T11:32:21Z","timestamp":1737631941000},"page":"197","source":"Crossref","is-referenced-by-count":20,"title":["Red Light Therapy for Myopia\u2014Current Regulatory Changes in China"],"prefix":"10.1001","volume":"143","author":[{"given":"Ya Xing","family":"Wang","sequence":"first","affiliation":[{"name":"Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningli","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7543","key":"evp240006r1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom.","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"issue":"6","key":"evp240006r2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/jamaophthalmol.2024.0801","article-title":"Daily low-level red light for spherical equivalent error and axial length in children with myopia: a randomized clinical trial.","volume":"142","author":"Cao","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"evp240006r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9612","article-title":"Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial.","volume":"6","author":"He","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"evp240006r5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.oret.2021.10.003","article-title":"A Randomized trial of photobiomodulation therapy for center-involved diabetic macular edema with good visual acuity (protocol AE).","volume":"6","author":"Kim","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"evp240006r6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaophthalmol.2023.1548","article-title":"Retinal damage after repeated low-level red-light laser exposure.","volume":"141","author":"Liu","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"evp240006r7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/opo.13272","article-title":"Red light instruments for myopia exceed safety limits.","volume":"44","author":"Ostrin","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"key":"evp240006r3","unstructured":"China\u2019s National Medical Products Administration. Medical device regulatory letter\u2014notice on regulating the registration and management of laser myopia and amblyopia treatment devices. Article in Chinese. Accessed August 13, 2024. https:\/\/www.cmde.org.cn\/xwdt\/zxyw\/20240206154710114.html"},{"key":"evp240006r8","unstructured":"China\u2019s National Medical Products Administration. Announcement on the release of technical review points for laser devices used in myopia and amblyopia treatment. Article in Chinese. Accessed August 12, 2024. https:\/\/www.cmde.org.cn\/\/xwdt\/shpgzgg\/gztg\/20240206154710114.html"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2829208\/jamaophthalmology_wang_2025_vp_240006_1741981269.17827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T12:21:41Z","timestamp":1742473301000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2829208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.5977","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}